Certified by Founder
Lodge
StimOxyGen
start up
United Kingdom
- Coleraine, Derry
- 12/03/2025
- Unknown
- $1,939,450
StimOxyGen is a proprietary and world-leading innovative approach to address the global challenge of tumour hypoxia.
Hypoxia, or lack of oxygen, is a common characteristic of solid tumours that contributes to the failure of many types of cancer treatment, particularly radiotherapy which relies on oxygen for maximum efficacy.
We can solve this longstanding major unmet clinical need by fueling tumours with oxygen to maximise therapeutic effects of radiotherapy.
- Industry Research Services
- Website https://stimoxygen.com/
- LinkedIn https://www.linkedin.com/company/stimoxygen/
Related People
Sian FarrellFounder
United Kingdom -
Londonderry, Northern Ireland
Co-founder and Chief Executive Officer at StimOxyGen.
WealthAi | $1,000,000 | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
Mesh Security | $12,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Co-reactive | $7,754,157 | (Jan 30, 2026)
Arkero | $6,000,000 | (Jan 30, 2026)
Redwood Materials | $425,000,000 | (Jan 30, 2026)
Twogee Biotech | $2,575,886 | (Jan 30, 2026)
Levellr | $2,500,000 | (Jan 30, 2026)
Indigo(1) | $50,000,000 | (Jan 30, 2026)
heyData | $16,500,000 | (Jan 30, 2026)